Funded Tech Companies
HDL Therapeutics
Researching who invested in HDL Therapeutics? Private investors, Aisling Capital and Domain Associates joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
HDL Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
46701 Commerce Center Dr.
Plymouth, MI 48170
USA
Plymouth, MI 48170
USA
Phone
Email Address
Not Recorded
Company Background Information
Overview
We are a privately held cardiovascular device company and a leader in the field of reversing coronary atherosclerosis. Our innovative acute care therapeutic device called PDS-2� System transforms a patient's own plasma into an atherosclerostic reversal agent using our patented technology.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/11/2017
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Roger Newton
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs